QuidelOrtho (QDEL) Revenue & Revenue Breakdown
QuidelOrtho Revenue Highlights
Latest Revenue (Y)
$2.78B
Latest Revenue (Q)
$613.90M
Main Segment (Y)
Other
Main Geography (Y)
North America Segment
QuidelOrtho Revenue by Period
QuidelOrtho Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2024-12-29 | $2.78B | -7.17% |
| 2023-12-31 | $3.00B | -8.21% |
| 2023-01-01 | $3.27B | 92.28% |
| 2021-12-31 | $1.70B | 2.22% |
| 2020-12-31 | $1.66B | 210.66% |
| 2019-12-31 | $534.89M | 2.41% |
| 2018-12-31 | $522.28M | 88.05% |
| 2017-12-31 | $277.74M | 44.96% |
| 2016-12-31 | $191.60M | -2.31% |
| 2015-12-31 | $196.13M | 7.40% |
| 2014-12-31 | $182.62M | 4.11% |
| 2013-12-31 | $175.41M | 12.63% |
| 2012-12-31 | $155.74M | -1.80% |
| 2011-12-31 | $158.60M | 39.94% |
| 2010-12-31 | $113.34M | -31.01% |
| 2009-12-31 | $164.28M | 28.21% |
| 2008-12-31 | $128.13M | 8.53% |
| 2007-12-31 | $118.06M | 11.37% |
| 2006-12-31 | $106.02M | 14.86% |
| 2005-12-31 | $92.30M | 17.29% |
| 2004-12-31 | $78.69M | -17.26% |
| 2003-12-31 | $95.11M | 24.69% |
| 2002-12-31 | $76.27M | 3.00% |
| 2001-12-31 | $74.06M | 8.35% |
| 2000-12-31 | $68.35M | 44.81% |
| 1999-03-31 | $47.20M | 3.28% |
| 1998-03-31 | $45.70M | 9.07% |
| 1997-03-31 | $41.90M | 21.45% |
| 1996-03-31 | $34.50M | 10.93% |
| 1995-03-31 | $31.10M | 12.27% |
| 1993-03-31 | $27.70M | - |
QuidelOrtho generated $2.78B in revenue during NA 2024, up -7.17% compared to the previous quarter, and up 520.28% compared to the same period a year ago.
QuidelOrtho Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2025-06-29 | $613.90M | -11.39% |
| 2025-03-30 | $692.80M | -2.12% |
| 2024-12-29 | $707.80M | -2.65% |
| 2024-09-29 | $727.10M | 14.27% |
| 2024-06-30 | $636.30M | -10.34% |
| 2024-03-31 | $709.70M | -4.43% |
| 2023-12-31 | $742.60M | -0.19% |
| 2023-10-01 | $744.00M | 11.86% |
| 2023-07-02 | $665.10M | -21.39% |
| 2023-04-02 | $846.10M | -2.35% |
| 2023-01-01 | $866.50M | 10.55% |
| 2022-10-02 | $783.80M | 27.78% |
| 2022-07-03 | $613.40M | -38.80% |
| 2022-03-31 | $1.00B | 57.37% |
| 2021-12-31 | $636.87M | 24.94% |
| 2021-09-30 | $509.74M | 188.62% |
| 2021-06-30 | $176.61M | -52.95% |
| 2021-03-31 | $375.34M | -53.62% |
| 2020-12-31 | $809.20M | 69.98% |
| 2020-09-30 | $476.06M | 135.96% |
| 2020-06-30 | $201.75M | 15.52% |
| 2020-03-31 | $174.65M | 14.77% |
| 2019-12-31 | $152.18M | 20.31% |
| 2019-09-30 | $126.49M | 16.85% |
| 2019-06-30 | $108.25M | -26.84% |
| 2019-03-31 | $147.97M | 11.60% |
| 2018-12-31 | $132.59M | 12.94% |
| 2018-09-30 | $117.40M | 13.81% |
| 2018-06-30 | $103.16M | -39.01% |
| 2018-03-31 | $169.14M | 47.22% |
| 2017-12-31 | $114.89M | 125.74% |
| 2017-09-30 | $50.89M | 33.00% |
| 2017-06-30 | $38.27M | -48.07% |
| 2017-03-31 | $73.69M | 39.55% |
| 2016-12-31 | $52.81M | 7.03% |
| 2016-09-30 | $49.34M | 26.09% |
| 2016-06-30 | $39.13M | -22.23% |
| 2016-03-31 | $50.32M | -3.99% |
| 2015-12-31 | $52.41M | 11.96% |
| 2015-09-30 | $46.81M | 34.24% |
| 2015-06-30 | $34.87M | -43.11% |
| 2015-03-31 | $61.30M | -3.61% |
| 2014-12-31 | $63.60M | 55.66% |
| 2014-09-30 | $40.86M | 29.75% |
| 2014-06-30 | $31.49M | -32.53% |
| 2014-03-31 | $46.67M | -6.97% |
| 2013-12-31 | $50.17M | 49.59% |
| 2013-09-30 | $33.54M | 12.90% |
| 2013-06-30 | $29.71M | -52.08% |
| 2013-03-31 | $61.99M | 14.97% |
| 2012-12-31 | $53.92M | 63.42% |
| 2012-09-30 | $33.00M | 6.93% |
| 2012-06-30 | $30.86M | -18.71% |
| 2012-03-31 | $37.96M | -1.12% |
| 2011-12-31 | $38.39M | 15.96% |
| 2011-09-30 | $33.11M | 20.35% |
| 2011-06-30 | $27.51M | -53.84% |
| 2011-03-31 | $59.59M | 87.94% |
| 2010-12-31 | $31.71M | 12.34% |
| 2010-09-30 | $28.23M | 12.78% |
| 2010-06-30 | $25.03M | -11.82% |
| 2010-03-31 | $28.38M | -57.39% |
| 2009-12-31 | $66.60M | 18.60% |
| 2009-09-30 | $56.15M | 127.86% |
| 2009-06-30 | $24.64M | 45.90% |
| 2009-03-31 | $16.89M | -49.56% |
| 2008-12-31 | $33.48M | 5.07% |
| 2008-09-30 | $31.87M | 45.41% |
| 2008-06-30 | $21.92M | -46.37% |
| 2008-03-31 | $40.87M | 7.59% |
| 2007-12-31 | $37.98M | - |
QuidelOrtho generated $613.90M in revenue during Q2 2025, up -11.39% compared to the previous quarter, and up 86.50% compared to the same period a year ago.
QuidelOrtho Revenue Breakdown
QuidelOrtho Revenue Breakdown by Product
Annual Revenue by Product
| Product/Service | Dec 23 | Jan 23 |
|---|---|---|
| Other | $483.30M | $302.70M |
QuidelOrtho's latest annual revenue breakdown by segment (product or service), as of Dec 23: Other (100.00%).
Quarterly Revenue by Product
| Product/Service | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Oct 23 | Jul 23 | Jan 23 | Oct 22 | Jul 22 |
|---|---|---|---|---|---|---|---|---|---|
| Other | $126.50M | $124.20M | $116.20M | $235.70M | $123.20M | $124.40M | $114.60M | $111.70M | $59.50M |
QuidelOrtho's latest quarterly revenue breakdown by segment (product or service), as of Sep 24: Other (100.00%).
QuidelOrtho Revenue Breakdown by Country
Annual Revenue by Country
| Country | Dec 24 | Dec 23 |
|---|---|---|
| China Segment | $325.00M | - |
| North America Segment | $1.62B | $1.88B |
| EMEA Segment | $335.80M | $327.30M |
| China | - | $310.10M |
| Other | - | $483.30M |
QuidelOrtho's latest annual revenue breakdown by geography, as of Dec 24: North America Segment (71.03%), EMEA Segment (14.72%), and China Segment (14.25%).
Quarterly Revenue by Country
| Country | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Oct 23 | Jul 23 | Apr 23 | Jan 23 | Oct 22 | Jul 22 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| North America Segment | $310.70M | $406.70M | $399.60M | $436.20M | $350.10M | $433.90M | $450.30M | $465.20M | $378.80M | $582.80M | $619.20M | $517.60M | $438.20M |
| EMEA Segment | $87.30M | $88.90M | $85.90M | $84.00M | $81.10M | $84.80M | $90.90M | $74.50M | $80.60M | $81.30M | $75.80M | $73.70M | $42.10M |
| China Segment | $83.40M | $75.00M | - | - | - | - | - | - | - | - | - | - | - |
| Other | - | - | - | $126.50M | $124.20M | $116.20M | $124.30M | $123.20M | $124.40M | $111.40M | $114.60M | $111.70M | $59.50M |
| China | - | - | - | $80.40M | $81.60M | $76.10M | $147.70M | $81.10M | $81.30M | $56.90M | $80.80M | $73.60M | - |
| CHINA | - | - | - | - | - | - | - | - | - | $70.60M | - | - | - |
QuidelOrtho's latest quarterly revenue breakdown by geography, as of Jun 25: North America Segment (64.54%), EMEA Segment (18.13%), and China Segment (17.32%).
QuidelOrtho Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| QDEL | QuidelOrtho | $2.78B | $613.90M |
| TLRY | Tilray Brands | $821.31M | $209.50M |
| AZTA | Azenta | $656.32M | $143.94M |
| NVCR | NovoCure | $605.22M | $154.99M |
| ATRC | AtriCure | $465.31M | $136.14M |
| RCUS | Arcus Biosciences | $258.00M | $160.00M |
| LMAT | LeMaitre Vascular | $219.86M | $64.23M |
| CLDX | Celldex Therapeutics | $7.02M | $695.00K |
| GPCR | Structure Therapeutics | - | - |
| VRDN | Viridian Therapeutics | - | - |
| BHVN | Biohaven | - | - |